-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Lz1bYnErbzbI7AxxuL4b+n7rhaIFzKLn/QSCdcjGyCXm0FyA3uW9LxH62INiW0uO
 CHUEjEmWX2IqOqHhhIeZzQ==

<SEC-DOCUMENT>0001125282-04-000336.txt : 20040206
<SEC-HEADER>0001125282-04-000336.hdr.sgml : 20040206
<ACCEPTANCE-DATETIME>20040206170923
ACCESSION NUMBER:		0001125282-04-000336
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20040204
FILED AS OF DATE:		20040206

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EYETECH PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001115285
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				134104684
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		500 SEVENTH AVE 18TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018
		BUSINESS PHONE:		2129979241

	MAIL ADDRESS:	
		STREET 1:		500 SEVENTH AVE 18TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JPMP MASTER FUND MANAGER L P
		CENTRAL INDEX KEY:			0001243235
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50516
		FILM NUMBER:		04575127

	BUSINESS ADDRESS:	
		STREET 1:		JP MORGAN PARTNERS LLC
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		212 899-3400

	MAIL ADDRESS:	
		STREET 1:		C/O JPMORGAN PARTNERS LLC
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FL.
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JP MORGAN PARTNERS BHCA LP
		CENTRAL INDEX KEY:			0001106607
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50516
		FILM NUMBER:		04575128

	BUSINESS ADDRESS:	
		STREET 1:		J.P. MORGAN PARTNERS
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		2128993400

	MAIL ADDRESS:	
		STREET 1:		J.P. MORGAN PARTNERS
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020

	FORMER NAME:	
		FORMER CONFORMED NAME:	CHASE EQUITY ASSOCIATES LLC
		DATE OF NAME CHANGE:	20000214

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			J P MORGAN CHASE & CO
		CENTRAL INDEX KEY:			0000019617
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50516
		FILM NUMBER:		04575130

	BUSINESS ADDRESS:	
		STREET 1:		270 PARK AVE
		STREET 2:		39TH FL
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		2122706000

	MAIL ADDRESS:	
		STREET 1:		270 PARK AVENUE
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER NAME:	
		FORMER CONFORMED NAME:	CHASE MANHATTAN CORP /DE/
		DATE OF NAME CHANGE:	19960402

	FORMER NAME:	
		FORMER CONFORMED NAME:	CHEMICAL BANKING CORP
		DATE OF NAME CHANGE:	19920703

	FORMER NAME:	
		FORMER CONFORMED NAME:	CHEMICAL NEW YORK CORP
		DATE OF NAME CHANGE:	19880508

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			JPMP CAPITAL CORP
		CENTRAL INDEX KEY:			0001243236
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50516
		FILM NUMBER:		04575131

	BUSINESS ADDRESS:	
		STREET 1:		C/O J.P. MORGAN PARTNERS, LLC
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		212 899-3400

	MAIL ADDRESS:	
		STREET 1:		C/O JPMORGAN PARTNERS
		STREET 2:		1221 AVENUE OF THE AMERICAS 40TH FL.
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020

	FORMER NAME:	
		FORMER CONFORMED NAME:	JPMP CAPITAL LLC
		DATE OF NAME CHANGE:	20030618
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>b330027_ex.xml
<DESCRIPTION>STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0201</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2004-02-04</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001115285</issuerCik>
        <issuerName>EYETECH PHARMACEUTICALS INC</issuerName>
        <issuerTradingSymbol>EYET</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001106607</rptOwnerCik>
            <rptOwnerName>JP MORGAN PARTNERS BHCA LP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>J.P. MORGAN PARTNERS</rptOwnerStreet1>
            <rptOwnerStreet2>1221 AVENUE OF THE AMERICAS 40TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001243235</rptOwnerCik>
            <rptOwnerName>JPMP MASTER FUND MANAGER L P</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>JP MORGAN PARTNERS LLC</rptOwnerStreet1>
            <rptOwnerStreet2>1221 AVENUE OF THE AMERICAS 40TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001243236</rptOwnerCik>
            <rptOwnerName>JPMP CAPITAL CORP</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O J.P. MORGAN PARTNERS, LLC</rptOwnerStreet1>
            <rptOwnerStreet2>1221 AVENUE OF THE AMERICAS 40TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10020</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0000019617</rptOwnerCik>
            <rptOwnerName>J P MORGAN CHASE &amp; CO</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>270 PARK AVE</rptOwnerStreet1>
            <rptOwnerStreet2>39TH FL</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10017</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2004-02-04</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>C</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>1838235</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>4289215</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2004-02-04</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>C</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>1736111</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>4289215</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2004-02-04</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>367647</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>6.80</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>4289215</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2004-02-04</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>347222</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>7.20</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>4289215</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Director Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.44</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2002-12-03</value>
            </exerciseDate>
            <expirationDate>
                <value>2012-12-03</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>60000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>60000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See Footnote</value>
                    <footnoteId id="F1"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeTransaction>
            <securityTitle>
                <value>Series C-1 Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2004-02-04</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>C</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>1838235</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F3"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>1838235</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
        <derivativeTransaction>
            <securityTitle>
                <value>Series C-2 Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F2"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2004-02-04</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>C</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>1736111</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F3"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>1736111</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
        <derivativeTransaction>
            <securityTitle>
                <value>Series C-1 Warrant (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>6.80</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2004-02-04</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>X</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>367647</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>6.80</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2001-07-24</value>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F4"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>367647</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
        <derivativeTransaction>
            <securityTitle>
                <value>Series C-2 Warrant (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>7.20</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2004-02-04</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>X</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>347222</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>7.20</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2002-08-22</value>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F5"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>347222</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">These options were granted to Damion Wicker and Srinivas Akkaraju, directors of the Issuer.  Mr. Wicker is Managing Director of JPMP Capital Corp., the general partner of JPMP Master Fund Manager, L.P. (&quot;MF Manager&quot;), the general partner of J.P. Morgan Partners (BHCA), L.P. (&quot;JPM BHCA&quot;).  Mr. Akkaraju is a Principal at J.P. Morgan Partners, LLC and a limited partner of MF Manager.  Mr. Wicker and Mr. Akkaraju are obligated to transfer any shares issued under the stock option to JPM BHCA.</footnote>
        <footnote id="F2">These shares are convertible on a one for one basis.</footnote>
        <footnote id="F3">The Series C-1 and Series C-2 Convertible Preferred Stock is immediately exercisable.  It has no expiration date.  Upon the close of the Issuer's initial public offering, these shares were automatically converted into Common Stock of the Issuer.</footnote>
        <footnote id="F4">Warrant to purchase Series C-1 Convertible Preferred Stock at an exercise price of $6.80 per share.  The Warrant expires upon the earlier of the closing of the Issuer's initial public offering by Common Stock and, July 23, 2008.  The shares of Series C-1 Convertible Preferred Stock underlying the Warrant are convertible on a one for one basis into shares of Common Stock.</footnote>
        <footnote id="F5">Warrant to purchase Series C-2 Convertible Preferred Stock at an exercise price of $7.20 per share.  The Warrant expires upon the earlier of the closing of the Issuer's initial public offering of Common Stock and, July 23, 2008.  The shares of Series C-2 Convertible Preferred Stock underlying the Warrant are convertible on a one for one basis into shares of Common Stock.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Damion E. Wicker</signatureName>
        <signatureDate>2004-02-06</signatureDate>
    </ownerSignature>
</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>b330027_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head><title>
Prepared and filed by St Ives Burrups
</title>
</head>
<body bgcolor="#FFFFFF">
<p align="right"><font size="2" face="serif"><b>Exhibit
    99.1</b></font></p>
<p align="left"><font size="2" face="serif"><b>J.P. Morgan Partners (BHCA), L.P./Eyetech Pharmaceuticals, Inc.</b></font></p>

	<table width="100%" border="1" cellpadding="4" cellspacing="0" bordercolor="#000000">
<tr valign="bottom">
<td width="18%" align="center"><font size="2" face="serif"><b>Name and <br>
  Address of <br>
  Reporting Person<sup>(1)</sup></b></font></td>
<td width="10%"><div align="center"><font size="2" face="serif"><b>Designated Reporter<sup>(1)</sup></b></font></div></td>
<td width="8%" align="center"><font size="2" face="serif"><b>Statement for Month/Day/Year</b></font></td>
<td width="10%" align="center"><font size="2" face="serif"><b>Deemed Execution<br>
      Date, if any</b></font><br>
  <font size="2" face="serif"><b>(Month/Day/Year </b></font></td>
<td width="12%" align="center"><font size="2" face="serif"><b>Issuer Name, Ticker</b></font><br>
  <font size="2" face="serif"><b>or Trading Symbol</b></font></td>
<td width="9%"><div align="center"><font size="2" face="serif"><b>Title of </b></font><br>
      <font size="2" face="serif"><b>Security</b></font></div></td>
<td width="12%" align="center"><font size="2" face="serif"><b>Amount of<br>
Securities<br>
Beneficially<br>
Owned<sup>(1)</sup></b></font></td>
<td width="12%" align="center"><font size="2" face="serif"><b>Title of Derivative<br>
  Securities and Title and<br>Amounts of<br>
  Securities Underlying Derivative Securities</b></font></td>
<td width="9%" align="center"><font size="2" face="serif"><b>Ownership Form:</b></font> <font size="2" face="serif"><b>Direct
      (D) or</b></font> <font size="2" face="serif"><b>Indirect (I)</b></font></td>
<td width="9%" align="center"><font size="2" face="serif"><b>Nature of<br>
  Indirect</b></font><br>  <font size="2" face="serif"><b>Beneficial Ownership<sup>(1)</sup></b></font></td>
<td><div align="center"><font size="2" face="serif"><b>Disclaims</b></font><br>
      <font size="2" face="serif"><b>Pecuniary Interest</b></font></div></td>
</tr>
<tr valign="bottom">
<td align="left"><font size="2" face="serif">JPMP Master Fund Manager, L.P.
c/o J.P. Morgan Partners, LLC<br>
1221 Avenue of the Americas,<br>
40th Floor New York, NY 10020
</font></td>
<td align="center"><font size="2" face="serif">J.P. Morgan Partners (BHCA), L.P.</font></td>
<td align="center"><font size="2" face="serif">February 4, 2004</font></td>
<td align="center"><font size="2" face="serif">N/A</font></td>
<td align="center">Eyetech Pharmaceuticals, Inc.
(&#147;EYET&#148;)</td>
<td align="center"><font size="2" face="serif">N/A</font></td>
<td align="center"><font size="2" face="serif">N/A</font></td>
<td align="center"><font size="2" face="serif">See Tables I and II</font></td>
<td align="center"><font size="2" face="serif">I</font></td>
<td align="left"><font size="2" face="serif">See Explanatory<br>
  Note 2 below</font></td>
<td align="center"><font size="2" face="serif">No</font></td>
</tr>
<tr valign="bottom">
<td align="left"><font size="2" face="serif">JPMP Capital Corporation<br>
c/o J.P. Morgan Partners, LLC<br>
1221 Avenue of the Americas, 40th Floor<br>
New York, NY 10020</font></td>
<td align="center"><font size="2" face="serif">J.P. Morgan Partners (BHCA), L.P.</font></td>
<td align="center"><font size="2" face="serif">February 4, 2004</font></td>
<td align="center"><font size="2" face="serif">N/A</font></td>
<td align="center">Eyetech Pharmaceuticals, Inc.
(&#147;EYET&#148;)</td>
<td align="center"><font size="2" face="serif">N/A</font></td>
<td align="center"><font size="2" face="serif">N/A</font></td>
<td align="center"><font size="2" face="serif">See Tables I and II</font></td>
<td align="center"><font size="2" face="serif">I</font></td>
<td align="left"><font size="2" face="serif">See Explanatory Note 3 below</font></td>
<td align="center"><font size="2" face="serif">No</font></td>
</tr>
<tr valign="bottom">
<td align="left"><font size="2" face="serif">J.P. Morgan Chase & Co.<br>
270 Park Avenue 35th Floor<br>
New York, NY 10017
</font></td>
<td align="center"><font size="2" face="serif">J.P. Morgan Partners (BHCA), L.P.</font></td>
<td align="center"><font size="2" face="serif">February 4, 2004</font></td>
<td align="center"><font size="2" face="serif">N/A</font></td>
<td align="center">Eyetech Pharmaceuticals, Inc.
(&#147;EYET&#148;)</td>
<td align="center"><font size="2" face="serif">N/A</font></td>
<td align="center"><font size="2" face="serif">N/A</font></td>
<td align="center"><font size="2" face="serif">See Tables I and II</font></td>
<td align="center"><font size="2" face="serif">I</font></td>
<td align="left"><font size="2" face="serif">See Explanatory<br>
  Note 4 below</font></td>
<td align="center"><font size="2" face="serif">No</font></td>
</tr>
</table>
<p align="left"><font size="2" face="serif">Explanatory Note:</font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"><font size="2" face="serif">1)</font></td>
<td align="left">
<font size="2" face="serif">The Designated Reporter is executing this
report on behalf of all Reporting Persons, each of whom has authorized it to
do so; each of such Persons disclaims beneficial ownership of the Issuer&#146;s securities
to the extent it exceeds such Person&#146;s pecuniary interest therein.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"><font size="2" face="serif">2)</font></td>
<td align="left">
<font size="2" face="serif">The amounts shown represent the beneficial ownership of
 the Issuer&#146;s equity securities by JPM BHCA, a portion of which may be
  deemed attributable to the Reporting Person because the Reporting Person
   is the general partner of JPM BHCA.  The actual pro rata portion of such
   beneficial ownership that may be deemed to be attributable to the Reporting
   Person is not readily determinable because it is subject to several variables,
   including the internal rate of return and vesting of interests within JPM BHCA.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"><font size="2" face="serif">3)</font></td>
<td align="left">
<font size="2" face="serif">The amounts shown represent the beneficial ownership of
the Issuer&#146;s equity securities by JPM BHCA, a portion of which may be deemed
attributable to the Reporting Person because it is the general partner of JPMP Master Fund
Manager, L.P. (&#147;MF Manager&#148;), the general partner of JPM BHCA.  The actual
pro rata portion of such beneficial ownership that may be deemed attributable to the
Reporting Person is not readily determinable because it is subject to several variables,
 including the internal rate of return and vesting of interests within JPM BHCA and MF
 Manager.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
</table>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="3%"><font size="2" face="serif">4)</font></td>
<td align="left">
<font size="2" face="serif">The amounts shown represent the beneficial
ownership of the Issuer&#146;s equity securities by JPM BHCA, a portion of which may
be deemed attributable to the Reporting Person because it is the sole stockholder
of (a) JPMP Capital Corporation, the general partner of MF Manager and (b)
Chatham Ventures, Incorporated, the limited partner of JPM BHCA.  The actual pro
rata portion of such beneficial ownership that may be deemed to be attributable to
the Reporting Person is not readily determinable because it is subject to several
variables, including the internal rate of return and vesting of interests within
JPM BHCA and MF Manager.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
</table>

<p>&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
</body>
</html>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
